Navigation Links
Medable Wins DPharm Idol Competition for Human Digitome as a Disruptive Application in Clinical Research
Date:9/27/2018

Medable was named DPharm Idol at this year’s DPharm conference. Medable is a platform that aims to build the first human digitome, a digital representation of human health and disease, by removing the separation between clinical trial and real-world data through a seamless integration of all data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that their approach aims to transform clinical trials by building a connected team of researchers and patients through providing rich digital experiences on their mobile app for the patient. Through the digitome, they hope to transform the idea of health from a binary perspective to one that is complex and includes actionable, real-world insights.

Medable had an extremely short time to present their goals in disrupting the current paradigm of clinical trials and pitch their product to our esteemed panel of judges, which consisted of:

Esther Dyson
Executive Founder, Way to Wellville

Sandra Freeman
Associate Director, Global Clinical Operations, Johnson and Johnson

Cindy Geoghegan
Patient Advocate

Rob Goodwin
VP, Operations Center of Excellence, Global Product Development, Pfizer

Christian Gossens, PhD, MBA
Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)

Hassan Kadhim, MSc
Senior Associate Director, Head, IT Clinical Trial Planning & Management, Boehringer Ingelheim Pharmaceuticals, Inc

Joseph Kim, MBA
Sr Advisor, Patient Experience and Design Innovation Design Hub Foundations, Eli Lilly and Company

Jacob LaPorte, PhD
Head of Digital Development, Novartis

Chandra Ramanathan, PhD, MBA
Head, East Coast Innovation Center, Bayer, US

Dan Rothman
Chief Information Officer, Roivant Sciences

John Varaklis
Head of Global Clinical Operations, Roche Pharmaceutical Research and Early Development (pRED)

The judges mentioned that disruption is about possibility, and Medable’s idea of a human digitome provides a new possibility to explore data that did not exist before, by creating an ecosystem of the patient’s data both in clinical trials and in the real world. Several of the judges made comments about the potential of the digitome to transform healthcare, with Hassan Kadhim explaining that the technology is “very much futuristic and we’d love to see it implemented.”

The panel of judges deliberated for two hours to determine the winner. The judging process was not easy, as Esther Dyson commented, “I gave a 5 to everyone on the list, in the terms that they were all solving a lot of problems we have within clinical trials.” Although they were triumphant, Medable had strong competition from our other DPharm Idol presenters:

Edetek
Peter Smilansky, SVP of Product Strategy

Quest Diagnostics
David Freeman, MBA, General Manager, Information Ventures

WCG
Steven Beales, SVP IT and Market Owner, Safety Solutions

Clinical Pipe
Amit Shah, Founder and Chief Technology Officer

BioSensics
Joseph Gwin, PhD, VP of R&D

DPharm Idol is the signature event that took place at the 8th annual iteration of DPharm: Disruptive Innovations to Advance Clinical Trials. DPharm, organized by the Conference Forum, is the event that connects industry, biotech, clinical research partners, as well as patient advocate groups to inspire and encourage the most innovative technologies and ideas in clinical trials and drug development. Mark your calendars for next year’s event, which will be held September 17-18, 2019.

Read the full story at https://www.prweb.com/releases/medable_wins_dpharm_idol_competition_for_human_digitome_as_a_disruptive_application_in_clinical_research/prweb15792406.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. DPharm Disruptive Innovator of the Year Announced
2. 7th Annual DPharm: Disruptive Innovations to Advance Clinical Trials Conference Confirms Program Line-up for September 7-8, 2017
3. PhysIQ Personalized Physiology Analytics (PPA) Wins DPharm Idol 2017
4. China Engineering Plastics Industry will Reach US$5 Million By 2017 - Engineering Plastics Market, Share, Size, Analysis, Market Scale, Competition and Forecast 2013-2017
5. New England Biolabs supports iGEM synthetic biology competition
6. Surprise: Flu Vaccine Prevents Heart Attacks and Strokes; New Study on Flu Vaccine Supports Dr. Hanan Polansky’s Microcompetition Theory
7. Enteroviruses Cause Type 1 Diabetes; New Studies Support Dr. Hanan Polansky’s Microcompetition Theory
8. Clinical Research Coordinator From PMG Research of Bristol Wins 3rd Place in US Clinical Researcher of the Year Competition
9. Surprise: Viruses Can Cause Disease during Latent Phase; New Evidence Supports Microcompetition Theory
10. West Coast Bird Dog Champion Returns to Competition Thanks to Stem Cell Therapy by Vet-Stem, Inc.
11. California and New York Students Capture $100,000 Scholarship Prizes in 2013 Siemens Competition in Math, Science & Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2018)... , ... October 11, 2018 , ... ... label printing and software solutions, in collaboration with HP, the global leader in ... Avery UltraDuty GHS Chemical Labels on all HP PageWide Printers. , The award-winning ...
(Date:10/5/2018)... Pa. (PRWEB) , ... October 04, 2018 , ... ... a new brand identity and website that elevates the company’s brand identity and ... EARTHRES, the company offers a broader range of engineering expertise and related support ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... endangers the reliability and reproducibility of experimental data. Each lab must consider whether ... educational webinar, which is sponsored by Eppendorf , attendees will learn how ...
(Date:9/28/2018)... (PRWEB) , ... September 28, 2018 , ... ... virtual events for tech innovators, engineers, and scientists from around the world, is ... the National University of San Marcos, as the winner of the LabRoots Summer ...
Breaking Biology Technology:
(Date:10/5/2018)... ... October 04, 2018 , ... High dose of biotin may cause ... such as cardiac troponin has serious clinical complications. There is an increasing trend of ... still unknown. , High dose of biotin supplement use may continue to increase ...
(Date:10/2/2018)... ... October 02, 2018 , ... Stem Cell Innovations (SCI), ... and access to stem cell therapy, has launched the pre-sale for their ICO ... dual blockchain-based platform that will connect patients and stem cell specialists around the world. ...
(Date:10/2/2018)... ... October 02, 2018 , ... As ... ACEA Biosciences, The Cell Analysis Company , is excited to offer ... applications. Experimental design and data analysis for immune oncology researchers are now much ...
Breaking Biology News(10 mins):